An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.569
https://www.valueinhealthjournal.com/article/S1098-3015(13)02474-1/fulltext
Title :
An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02474-1&doi=10.1016/j.jval.2013.08.569
First page :
A422
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
547